Cargando…
Rhenium-188 Hydroxyethane 1,1-Diphosphonic Acid (HEDP) for Bone Pain Palliation Using BARC-HEDP Kits versus Pars-HEDP Kits: A Comparison on Preparation and Performance Aspects at Hospital Radiopharmacy
PURPOSE OF THE STUDY: Rhenium-188 hydroxyethane 1,1-diphosphonic acid (HEDP) is a clinically established radiopharmaceutical for palliation of bone pain due to osseous metastases. Recently, the Bhabha Atomic Research Centre (BARC) had developed a freeze-dried kit for the preparation of rhenium-188 H...
Autores principales: | Ramakurup, Radhakrishnan Edathuruthy Kalarickal, Chirayil, Viju, Pandiyan, Arun, Mallia, Madhava Balakrishna, Kameswaran, Mythili, Shinto, Ajit, Dash, Ashutosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194777/ https://www.ncbi.nlm.nih.gov/pubmed/30386051 http://dx.doi.org/10.4103/ijnm.IJNM_39_18 |
Ejemplares similares
-
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases
por: Liepe, K, et al.
Publicado: (2003) -
(188)Re-HEDP therapy in the therapy of painful bone metastases
por: Liepe, Knut
Publicado: (2018) -
Advanced high resolution x-ray diagnostic for HEDP experiments
por: Faenov, A. Y., et al.
Publicado: (2018) -
Efficacy of EDTA and HEDP Chelators in the Removal of Mature Biofilm of Enterococcus faecalis by PUI and XPF File Activation
por: Álvarez-Sagües, Alejandro, et al.
Publicado: (2021) -
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
por: Savio, Eduardo, et al.
Publicado: (2001)